Iproteos
Iproteos is a Barcelona-based early-stage biopharmaceutical spin-out (2011) commercializing technology transferred from IRB Barcelona and the University of Barcelona, backed by life-sciences investors; specific drug-discovery platform and pipeline are not disclosed in available data.
- Company typePrivate
- Founded2011
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingServices
Iproteos firmographics
Firmographics- Name
- Iproteos
- Website
- https://iproteos.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Iproteos is a Barcelona-based early-stage biopharmaceutical spin-out (2011) commercializing technology transferred from IRB Barcelona and the University of Barcelona, backed by life-sciences investors; specific drug-discovery platform and pipeline are not disclosed in available data.
- Ownership category
- akta.pro rank
Where Iproteos is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Markets served
Iproteos business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
Iproteos product offering
Product offeringCore offering
Iproteos is a Barcelona-based biotechnology company founded in 2011 through technology transfer from IRB Barcelona and the University of Barcelona. The company is built on proprietary protein- and peptide-based drug discovery technology originating from these academic research institutions, and operates in the early-stage biopharmaceutical R&D space with 1-10 employees.
Differentiator
Problem solved
Functional benefit
Companies that use Iproteos
Customer profileIdeal customer profiles1 record
Iproteos technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Iproteos competitors and assessment
Company assessmentDirect peers
- BCN Peptides: Barcelona-based peptide research and manufacturing company. Closely comparable to Iproteos given shared geography, peptide-focused technology base, and roots in the Catalan biomedical ecosystem.
Regional players
- Minoryx Therapeutics: Barcelona-based clinical-stage biotech developing treatments for rare neurological diseases. Comparable as a Catalan biotech spinoff of similar vintage operating in CNS-related indications.
- Ability Pharmaceuticals: Barcelona-area biotech developing small-molecule oncology drugs. Comparable as another Catalan-region early-stage biotech with academic roots and limited capital scale.
- Oryzon Genomics: Barcelona-based publicly listed biotech focused on epigenetic therapies. Comparable given shared Barcelona base, academic spinoff heritage, and small-molecule/biologics discovery model.
Emerging players
- Spherium Biomed: Barcelona-based early-stage biotech portfolio company. Comparable as a fellow small Catalan biotech developing biomedical assets from academic transfer with similar capital constraints.
Broad incumbents
- Zealand Pharma: Danish clinical-stage biopharma specializing in peptide-based therapeutics. Comparable as a peptide-therapeutics specialist operating at much larger scale than Iproteos would target.
Market position
Customer concentration
Iproteos social profiles
Digital presenceIproteos financial estimates
Financial estimateRevenue estimate
Valuation estimate
Iproteos leadership team
Management profileNumber of profiles
Iproteos funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Iproteos M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Iproteos
What does Iproteos do?
Iproteos is a Barcelona-based biotechnology company founded in 2011 through technology transfer from IRB Barcelona and the University of Barcelona. The company is built on proprietary protein- and peptide-based drug discovery technology originating from these academic research institutions, and operates in the early-stage biopharmaceutical R&D space with 1-10 employees.
When was Iproteos founded?
Iproteos was founded in 2011. It employs 1 to 10 people.
Where is Iproteos based?
Iproteos is headquartered in Barcelona, Spain, in the Europe region.
Who are Iproteos's main competitors?
BCN Peptides is listed as a direct peer. Regional players are Minoryx Therapeutics, Ability Pharmaceuticals and Oryzon Genomics. Spherium Biomed is listed as an emerging player. Zealand Pharma is listed as a broad incumbent.
Does Iproteos have an API?
No public API is recorded for Iproteos.